Medicine and HealthNature
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
R. K. Suryawanshi, I. P. Chen, et al.
This study by authors including Rahul K. Suryawanshi and Irene P. Chen explores the intriguing landscape of cross-variant immunity following Omicron infection. It reveals that while Omicron infection shows limited immune response and milder symptoms compared to Delta, it raises questions about the potential for broader protection among unvaccinated individuals. Dive into this compelling research to uncover the nuances of variant immunity!
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
Y. Guo, G. Zhang, et al.
Medicine and Health
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
L. Pérez-alós, C. B. Hansen, et al.
Medicine and Health
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
J. Zou, C. Kurhade, et al.
Medicine and Health
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
X. Chi, Y. Guo, et al.
